Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 13 November 2017 |
| Author/s |
author: Beverly Moy Suzette Delaloge Robert Šeparović Bent Ejlertsen Hiroji Iwata Kenichi Inoue Bruno Coudert |
| Publication date | November 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |